NCT05775549 - A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

October 27, 2023

Study Completion Date

October 27, 2023

Conditions

Advanced Ovarian Cancer

Interventions

OTHER

None (Observational Study)

Not Applicable since observational study

Trial Locations (7)

Research Site, New York

Research Site, Baltimore

Research Site, Annapolis

Research Site, Charlotte

Research Site, Tampa

Research Site, Madison

Research Site, Shreveport